BrainStorm Cell Therapeutics recently presented data from its Phase 2 clinical trial, showing that the company’s NurOwn stem cells technology…
Articles by Margarida Azevedo, MSc
Cytokinetics recently presented patient baseline characteristics from its VITALITY-ALS clinical trial investigating Tirasemtiv for the treatment of amyotrophic…
Origent Data Sciences and Cytokinetics reported results from the first part of a research partnership to further refine and validate an…
The biopharma Neurimmune and the venture capital fund TVM Life Science Ventures VII announced they have created a Swiss company called…
The Smithsonian’s National Museum of American History opened its long-term exhibition “Giving in America” on Nov. 29 to…
ALS League Belgium, a patient organization helping the families of people with amyotrophic lateral sclerosis (ALS), raised €302,000…
The Focused Ultrasound Foundation has recognized Sunnybrook Health Sciences Centre in Toronto, Canada, as a Centre of Excellence…
The ALS Association is awarding a $2 million grant to the ALS ONE-Massachusetts Partnership that will partially sponsor a University…
The European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP) has issued a positive opinion recommending that ibudilast…
New research points to evidence that physical fitness, body mass index (BMI), IQ, and stress resilience in young adults might…